Denali Therapeutics (NasdaqGS:DNLI) 2025 Investor Day Transcript

Denali Therapeutics (NasdaqGS:DNLI) 2025 Investor Day December 04, 2025 08:30 AM ET Company ParticipantsJoe Lewcock - Chief Scientific OfficerAnanda Ghosh - VP Biotech Equity ResearchBarbara Burton - Lead InvestigatorSean Laaman - Executive DirectorRyan Watts - CEOKatie Peng - Chief Commercial OfficerKim Stevens - Community and Clinical LeadJoseph Muenzer - PhysicianDana Anderson - Chief Technical and Manufacturing OfficerJason Madison - Patient AdvocateCharlie Moore - Senior Biotech Equity Research Associa ...